The involvement of prominent investment firms like Glenview, Sachem Head, and Third Point in increasing their stakes in CVS Health suggests confidence in the company's future prospects and potential strategic changes. This could positively impact CVS's stock price in the short term as investors may anticipate improvements or restructuring.